Skip to main content

Advertisement

SpringerLink
Log in

Left Ventricular Hypertrophy in Hypertensive Children and Adolescents: Predictors and Prevalence

  • Pediatric Hypertension (JT Flynn, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Left ventricular hypertrophy is an independent predictor of cardiovascular morbidity and mortality in adults. In children, the primary correlate of left ventricular mass (LVM) is lean body mass, but fat mass, gender and systolic blood pressure are also contributors. LVM can be estimated from echocardiographic measurements, and by indexing this allometrically to height to the 2.7 power, the left ventricular mass index (LVMI) can be calculated. LVMI optimizes detection of left ventricular hypertrophy with established normal curves for children from birth to 18 years. In children with sustained hypertension, 8–41 % have LVMI above the 95th percentile and in 10–15.5 % of these, LVMI is elevated above levels associated with increased mortality in adults. The presence of obesity is associated with higher LVMI than is found in children with hypertension alone. In children with chronic kidney disease, left ventricular hypertrophy develops relatively early and becomes more prevalent as kidney function decreases. In summary, left ventricular hypertrophy is a sensitive marker of target organ damage in children with BP elevation, obesity and chronic kidney disease providing important management information.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–6.

    Article  PubMed  CAS  Google Scholar 

  2. Devereux RB, Roman MJ. Left ventricular hypertrophy in hypertension: stimuli, patterns and consequences. Hypertens Res. 1999;22:1–9.

    Article  PubMed  CAS  Google Scholar 

  3. Liao Y, Cooper RS, Durazzo-Arvizu R, et al. Prediction of mortality risk by different methods of indexing for left ventricular mass. J Am Coll Cardiol. 1997;29:641–7.

    Article  PubMed  CAS  Google Scholar 

  4. Daniels SR, Kimball TR, Morrison JA, et al. Effect of lean body mass, fat mass, blood pressure and sexual maturation on left ventricular mass in children and adolescents: statistical, biological and clinical significance. Circulation. 1995;92:3249–54.

    Article  PubMed  CAS  Google Scholar 

  5. Urbina EM, Gidding SS, Bao W, et al. Effect of body size, ponderosity and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation. 1995;91:2400–6.

    Article  PubMed  CAS  Google Scholar 

  6. Schieken RM, Schwartz PF, Goble MM. Tracking of left ventricular mass in children: race and sex consequences: the MCV Twin Study. Circulation. 1998;97:1901–6.

    Article  PubMed  CAS  Google Scholar 

  7. Malcolm DD, Burns TL, Mahoney LT, et al. Factors affecting left ventricular mass in childhood: the Muscatine study. Pediatrics. 1993;92:703–9.

    PubMed  CAS  Google Scholar 

  8. de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Amer Coll Cardiol. 1992;20:1251–60.

    Article  Google Scholar 

  9. • Khoury PR, Mitsnefes M, Daniels SR, et al. Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009;22:709–14. Based on M-mode echocardiograms in more than 2000 non-obese, healthy children curves were constructed for the 5th, 10th, 25th, 50th, 75th, 90th and 95th percentiles of LVM/height 2.7 . For children over 9 years of age, values >40 g/m 2.7 in girls and 45 kg/m 2.7 in boys can be used as the 95th %ile. For children less than 9 years, the reference curves must be used.

    Article  PubMed  Google Scholar 

  10. The Fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. National High Blood Pressure Working Group on High Blood Pressure in Children and Adolescents. Pediatrics 2004;114(Supplement 2):555-576.

    Google Scholar 

  11. Mancini GBJ, Dahloff B, Diez J. Surrogate markers for cardiovascular disease. Structural markers. Circulation. 2004;109(25 Suppl 1):IV22–30.

    PubMed  Google Scholar 

  12. Parati G, Pomidossi G, Albina F, et al. Relationship of 24 hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:93–8.

    Article  PubMed  CAS  Google Scholar 

  13. Daniels SR, Loggie JMH, Khoury P, et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97:1907–11.

    Article  PubMed  CAS  Google Scholar 

  14. Sorof JM, Cardwell G, Franco K, et al. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39:903–8.

    Article  PubMed  CAS  Google Scholar 

  15. Litwin M, Niemirska A, Sladowska J, et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol. 2006;21:811–9.

    Article  PubMed  Google Scholar 

  16. • Brady TM, Fivush B, Flynn JT, et al. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. J Pediatr. 2008;152:73–8. A cross-sectional evaluation of children with newly diagnosed hypertension shows that LVH is common and that neither the severity of casual BP elevation nor abnormal ABPM results are predictive of LVH.

    Article  PubMed  Google Scholar 

  17. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995;25:879–84.

    Article  PubMed  CAS  Google Scholar 

  18. • Richey PA, DiSessa TG, Somes GW, et al. Left ventricular geometry in children and adolescents with primary hypertension. Am J Hypertens. 2010;23:24–9. In a cross-sectional study of children and adolescents with hypertension, increased SBP and BMI were associated with LVH but eccentric LVH correlated only with elevated DBP.

    Article  PubMed  Google Scholar 

  19. Pruette CS, Fivush BA, Flynn JT, Brady TM. Effects of obesity and race on left ventricular geometry in hypertensive children. Pediatr Nephrol. 2013. doi:10.1007/s00467-013-2507-7. Epub ahead of print.

    PubMed  Google Scholar 

  20. Kavey RE, Kveselis DA, Atallah N, et al. White coat hypertension in childhood: evidence for en-organ effect? J Pediatr. 2006;150:491–7.

    Google Scholar 

  21. Litwin M, Niemirska A, Ruzicka M, et al. White coat hypertension in children: not rare and not benign? J Am Soc Hypertens. 2009;3:416–23.

    Article  PubMed  Google Scholar 

  22. Stabouli S, Kotsis V, Rizos Z, et al. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol. 2009;24:1545–51.

    Article  PubMed  Google Scholar 

  23. • Urbina EM, Khoury PR, McCoy CE, et al. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens. 2011;13:332–42. Ultrasound measures of vascular stiffness and LVH, showed a graded increase from normotension to pre-hypertension to hypertension in adolescents and young adults.

    Article  Google Scholar 

  24. Boutyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–5.

    Article  Google Scholar 

  25. Sorof JM, Alexandrov AV, Cardwell G, et al. Carotid intima-media thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics. 2003;111:61–6.

    Article  PubMed  Google Scholar 

  26. Litwin M, Trelewicz J, Wawer Z, et al. Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol. 2004;19:767–74.

    Article  PubMed  Google Scholar 

  27. Lande MB, Carson NL, Roy J, et al. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension. 2006;48:40–4.

    Article  PubMed  CAS  Google Scholar 

  28. Simonetti GD, Von Vigier RO, Wuhl E, et al. Ambulatory arterial stiffness index is increased in hypertensive childhood disease. Pediatr Res. 2008;64:303–7.

    Article  PubMed  Google Scholar 

  29. • Urbina EM, Dolan LM, McCoy CE, et al. Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults. J Pediatr. 2011;158:715–21. Five ultrasound measures of vascular stiffness were combined as a global stiffness index which was shown to correlate with LVM, independent of traditional cardiovascular risk factors.

    Article  PubMed  Google Scholar 

  30. Li X, Li S, Ulusoy E, Chen W, et al. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation. 2004;110:3488–92.

    Article  PubMed  Google Scholar 

  31. Messerli FH, Christie B, DeCaravalho JG, et al. Obesity and essential hypertension: hemodynamics, intravascular volume, sodium excretion and plasma rennin activity. Arch Intern Med. 1981;141:81–5.

    Article  PubMed  CAS  Google Scholar 

  32. Chinali M, de Simone G, Roman MJ, et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol. 2006;47:2267–73.

    Article  PubMed  Google Scholar 

  33. Woodiwiss AJ, Libhaber CD, Majane OHI, et al. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens. 2008;21:1144–51.

    Article  PubMed  Google Scholar 

  34. Hanevold C, Waller J, Daniels SR, et al. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. 2004;113:328–33.

    Article  PubMed  Google Scholar 

  35. McDonald SP, Craig JC, for the Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350:2637–9.

    Article  Google Scholar 

  36. Parekh RS, Carroll CE, Wolfe RA, et al. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr. 2002;141(2):191–7.

    Article  PubMed  CAS  Google Scholar 

  37. Mitsnefes M. Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol. 2008;23:27–39.

    Article  PubMed  Google Scholar 

  38. Johnstone LM, Jones CL, Grigg LE, et al. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int. 1996;50:998–1006.

    Article  PubMed  CAS  Google Scholar 

  39. Mitsnefes MM, Kimball TR, Kartal J, et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr. 2006;149:671–5.

    Article  PubMed  Google Scholar 

  40. Mitsnefes MM, Kimball TR, Witt SA, et al. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation. 2003;16(107):864–8.

    Article  Google Scholar 

  41. Mitsnefes MM, Daniels SR, Schwartz SM, et al. Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol. 2001;16(4):318–23.

    Google Scholar 

  42. • Furth SL, Abraham AG, Jerry-Fluker J, et al. Metabolic abnormalities, cardiovascular disease risk and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:2132–40. Among children with chronic kidney disease, growth failure, metabolic abnormalities and CVD risk factors including LVH increase in prevalence as GFR declines.

    Article  PubMed  CAS  Google Scholar 

  43. Mitsnefes MM, Daniels SR, Schwartz SM, et al. Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant. 2001;5:279–84.

    Article  PubMed  CAS  Google Scholar 

  44. Gruppen MP, Groothoff JW, Prins M, et al. Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int. 2003;63:1058–63.

    Article  PubMed  Google Scholar 

  45. • Shamszad P, Slesnick TC, O’Brian-Smith E, et al. Association between left ventricular mass index and cardiac function in pediatric dialysis patients. Pediatr Nephrol. 2012;27:835–41. Elevated LVMI is associated with decreased systolic and diastolic cardiac function in pediatric dialysis patients.

    Article  PubMed  Google Scholar 

  46. Mitsnefes MM, Kimball TR, Border WL, et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 2004;65:1461–6.

    Article  PubMed  Google Scholar 

  47. Saygili A, Yoldirin SV, Cengiz N, et al. Assessment of left ventricular diastolic function by tissue Doppler imaging in children with end-stage renal disease. Acta Pediatr. 2005;94:1055–9.

    Article  Google Scholar 

  48. Goodman WG, Goldin J, Kuizon BD, et al. Coronary calcification in young adults with end-stage renal disease undergoing dialysis. N Engl J Med. 2000;342:1478–83.

    Article  PubMed  CAS  Google Scholar 

  49. Groothoff JW, Gruppen MP, Offringa M, et al. Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol. 2002;13:2953–61.

    Article  PubMed  Google Scholar 

  50. Oh J, Wunsch R, Turzer R, et al. Advanced coronary and carotid arteriopathy in young adults with childhood –onset chronic renal failure. Circulation. 2002;106:100–10.

    Article  PubMed  Google Scholar 

  51. Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006;114(24):2710–38.

    Article  PubMed  Google Scholar 

  52. • Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol. 2012;23:578–85. In this review, presence of LVH and increased arterial stiffness in children on dialysis are identified as evidence that modifiable risk factors for accelerated atherosclerosis should be identified and treated.

    Article  PubMed  CAS  Google Scholar 

  53. Verdecchia P, Angeli F, Borgioni C, et al. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens. 2003;16:895–9.

    Article  PubMed  Google Scholar 

  54. Klingbeil AU, Schneider M, Martus P, et al. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115:41–6.

    Article  PubMed  Google Scholar 

  55. • Seeman T, Dostalek L, Gilik J. Control of hypertension in treated children and its association with target organ damage. Am J Hypertens. 2012;25:389–95. In children with hypertension, inadequate control of blood pressure identified using ABPM is associated with a significantly higher prevalence of LVH.

    Article  PubMed  CAS  Google Scholar 

  56. • Litwin M, Niemirska A, Sladowska-Kozlowska J, et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol. 2010;25:2489–99. In this series of children with primary hypertension, lifestyle intervention resulting in a decrease in waist circumference correlated with a significant decrease in LVMI, not seen with BP lowering alone.

    Article  PubMed  Google Scholar 

  57. • Kupferman JC, Paterno K, Mahgerefteh J, et al. Improvement of left ventricular mass with antihypertensive therapy in children with hypertension. Pediatr Nephrol. 2010;25:1513–8. In this small series, percentage change in systolic BP z-score correlated significantly with a decrease in LVMI.

    Article  PubMed  Google Scholar 

  58. • Sladowska-Kozlowska J, Litwin M, Niemirska A, et al. Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension. Pediatr Nephrol 2011;26:2201–2209.-2499. In this series of children with primary hypertension, decreases in central adiposity and insulin resistance were associated with a decrease in relative LV wall thickness after 1 year of pharmacologic and non-pharmacologic treatment.

  59. • Yoon EY, Cohn L, Rocchini A, et al. Use of diagnostic tests in adolescents with essential hypertension. Arch Pediatr Adolesc Med 2012;166(9)857–862. Review of a statewide Medicaid data base of adolescents with essential hypertension who had antihypertensive pharmacy records demonstrated that only 24 % of adolescents had undergone echocardiographic evaluation.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Rae-Ellen Kavey declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

  1. Division of Pediatric Cardiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14692, USA

    Rae-Ellen W. Kavey

Authors
  1. Rae-Ellen W. Kavey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rae-Ellen W. Kavey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kavey, RE.W. Left Ventricular Hypertrophy in Hypertensive Children and Adolescents: Predictors and Prevalence. Curr Hypertens Rep 15, 453–457 (2013). https://doi.org/10.1007/s11906-013-0370-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-013-0370-3

Keywords

Search

Navigation